期刊文献+

肉毒杆菌毒素注射及气囊扩张治疗贲门失弛缓症的比较研究 被引量:7

A Comparative Study on Treating Achaiasia by Balloon Dilatation and Botulinum Toxin Local Injection
下载PDF
导出
摘要 目的:比较气囊扩张及肉毒杆菌毒素治疗贲门失弛缓症的近、远期疗效。方法:对31例患者(扩张组18例,注射组13例)进行1个月和1年随访观察,通过对临床症状、X线钡餐检查、胃镜检查和食管测压等进行比较分析。结果:18例行肉毒杆菌毒素注射患者治疗前,下食管括约肌静息压(LESP)为(8.34±1.62)kPa,松弛率(LESR)为(30.45±3.36)%。治疗后1周LESP,降至(4.13±0.42)kPa,LESR为(50.87±3.47)%。13例行气囊扩张术患者治疗前LESP为(7.58±1.48)kPa,LESR为(29.45±2.29)%。治疗后1周LESP降至(4.53±0.38)kPa,LESR为(48.47±3.32)%。两者运动学参数改善无明显差异,但行气囊扩张术有贲门黏膜撕裂、擦伤、渗血等并发症。结论:肉毒杆菌毒素注射和气囊扩张均为治疗贲门失弛缓症安全有效的方法,但气囊扩张术并发症更多。 Objective: To evaluate the curative effect of balloon dilatation or botulinum toxin (BT) local injection on achalasia. Metheods: Thirty one patients with achalasia were divided into two groups, one group balloon dilation( n = 18) and another BT local injection ( n = 13), All cases were followed up 1 to 12 mouths. The clinical manifestation, esophagram, gastroscopy and esophagus pressure of two groups were analyzed. Results: Before local injection the lower esophagus sphincter pressure(LESP) was (8. 34 ± 1. 62) kPa and the taxation rate (LESR) (30. 45±3. 36)%. After injection the LESP was (4. 13±0. 42) kPa and LESR (50. 87± 3. 47)%. Before the treatment of ballon dialation LESP was(7. 58±1. 48) kPa and LESR (29. 45±2. 92)%. After treatment of ballon dialation the LESP was(4. 53±0. 38) kPa and LESR (48. 47±3. 23)% . There was no significant difference in esophagus kinematics between two groups. But there were mucosal laceration, abrasions and hemorrhage effusion in the group of ballon dilation. Conclusions: The two methods are all effective in treating achalasia, but it seems that the balloon dilation group may have more complications.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2003年第1期51-53,共3页 Journal of Nanjing Medical University(Natural Sciences)
关键词 肉毒杆菌素注射 气囊扩张术 贲门失驰缓症 对比分析 疗效 副反应 achalasia btulinum toxin injection balloon dilatation
  • 相关文献

参考文献10

  • 1Rattan S, Martin M, Delgado I, et al. Effect of vasoactive intestinal polypeptide(VIP) on the lower esophageal spincter pressure[J] . Proc Soc Exp Biol Med, 1997, 155(1):40. 被引量:1
  • 2Seeling MH, De Vault KR, Seeling SK, et al. Treatment of achalasia: recent advances in surgery [J]. J Chin Gastroenterol, 1999, 28:202 - 207. 被引量:1
  • 3National Insistutes of Health Consensus Deviopment Conference Statement. Clinical use of botulinum toxin[J]. Arch Neurol, 1997, 48:1294 - 1298. 被引量:1
  • 4Pasricha PJ, Rai R, Ravich WJ, et al. Intrasphincteric botulinum toxin for the treatment of achalasia[J]. N Engl J Med, 1999, 332:774 - 778. 被引量:1
  • 5Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response [J].Gastroenterology, 1998, 110:1410 - 1415. 被引量:1
  • 6Prakash C, Freedland KE, Chan MF, et al. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation; A surival analysis approach [J]. Am J Gastroenterol, 1999, 94:328 -333. 被引量:1
  • 7Hoffman BJ, Kanpple W, Bhutani MS, et al. Endoscopic ultrasound(EUS) guided injection of botulinum toxin for achalasia[J]. Am J Gastroenterol, 1999, 90: 1560. 被引量:1
  • 8Maiorana A, Fiorention E, Genova EG, et al. Echo-guided injection of botulinum toxin in pations with achalasia initial experience[J]. Endoscopy, 1999, 31:(s3 - s4): 810. 被引量:1
  • 9Veazi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial[J]. Gut, 1999, 44:231 -239. 被引量:1
  • 10Anne se V, Basciani M, Lomhardi G, et al. Perendoscopic injection of botulinum toxin is effective in achalasia after failure of pneumatic dialation[J]. Gastrointest Endosc, 1998,44:461 - 465. 被引量:1

同被引文献66

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部